Federated Hermes Inc. Has $273,000 Stock Position in Agilent Technologies, Inc. $A

Federated Hermes Inc. lessened its holdings in Agilent Technologies, Inc. (NYSE:A) by 82.7% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 2,128 shares of the medical research company’s stock after selling 10,153 shares during the quarter. Federated Hermes Inc.’s holdings in Agilent Technologies were worth $273,000 as of its most recent SEC filing.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its position in shares of Agilent Technologies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 33,997,845 shares of the medical research company’s stock worth $4,012,086,000 after purchasing an additional 589,219 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its stake in shares of Agilent Technologies by 10.7% in the second quarter. Massachusetts Financial Services Co. MA now owns 13,227,387 shares of the medical research company’s stock valued at $1,560,964,000 after buying an additional 1,273,994 shares during the period. Geode Capital Management LLC grew its position in Agilent Technologies by 1.6% during the second quarter. Geode Capital Management LLC now owns 7,319,530 shares of the medical research company’s stock worth $860,137,000 after buying an additional 115,183 shares in the last quarter. Generation Investment Management LLP increased its stake in Agilent Technologies by 15.9% during the 2nd quarter. Generation Investment Management LLP now owns 5,775,860 shares of the medical research company’s stock worth $681,609,000 after acquiring an additional 792,304 shares during the period. Finally, Norges Bank acquired a new position in Agilent Technologies in the 2nd quarter valued at $395,088,000. 87.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

A has been the topic of several analyst reports. Robert W. Baird increased their target price on Agilent Technologies from $142.00 to $165.00 and gave the stock an “outperform” rating in a report on Tuesday, November 25th. Bank of America increased their price objective on shares of Agilent Technologies from $150.00 to $165.00 and gave the stock a “neutral” rating in a research note on Tuesday, November 25th. JPMorgan Chase & Co. boosted their target price on shares of Agilent Technologies from $165.00 to $180.00 and gave the company an “overweight” rating in a research report on Tuesday, November 25th. Wells Fargo & Company upped their price target on shares of Agilent Technologies from $150.00 to $175.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Finally, HSBC initiated coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective for the company. Two analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus price target of $164.50.

Insider Activity

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 12,490 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The stock was sold at an average price of $150.00, for a total transaction of $1,873,500.00. Following the completion of the transaction, the chief executive officer owned 33,448 shares of the company’s stock, valued at $5,017,200. This represents a 27.19% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, VP Rodney Gonsalves sold 3,000 shares of the firm’s stock in a transaction on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total value of $464,970.00. Following the completion of the sale, the vice president directly owned 31,846 shares of the company’s stock, valued at $4,935,811.54. The trade was a 8.61% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last ninety days, insiders have sold 16,401 shares of company stock valued at $2,468,962. Insiders own 0.26% of the company’s stock.

Agilent Technologies Stock Up 0.1%

A opened at $129.76 on Monday. Agilent Technologies, Inc. has a 12 month low of $96.43 and a 12 month high of $160.27. The company has a current ratio of 1.96, a quick ratio of 1.52 and a debt-to-equity ratio of 0.45. The business’s 50-day moving average price is $139.96 and its 200-day moving average price is $135.26. The company has a market cap of $36.79 billion, a P/E ratio of 28.39, a P/E/G ratio of 3.76 and a beta of 1.30.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, beating the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion during the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a return on equity of 25.20% and a net margin of 18.75%.The business’s revenue was up 9.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. On average, equities analysts expect that Agilent Technologies, Inc. will post 5.58 EPS for the current year.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 28th. Shareholders of record on Tuesday, January 6th were given a $0.255 dividend. The ex-dividend date was Tuesday, January 6th. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.25. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.8%. Agilent Technologies’s dividend payout ratio is presently 22.32%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.